LIXT
Lixte Biotechnology Holdings Inc
NASDAQ: LIXT · HEALTHCARE · BIOTECHNOLOGY
$3.50
+0.00% today
Updated 2026-04-30
Market cap
$44.15M
P/E ratio
—
P/S ratio
20.35x
EPS (TTM)
$-1.26
Dividend yield
—
52W range
$1 – $6
Volume
0.0M
Lixte Biotechnology Holdings Inc (LIXT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-102.00%
ROA
-46.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $-488084.00 | — | — | — |
| 2007 | — | $-1.65M | — | — | — |
| 2008 | — | $-1.27M | — | — | — |
| 2009 | — | $-1.55M | — | — | — |
| 2010 | — | $-880250.00 | — | — | — |
| 2011 | — | $-2.07M | — | — | — |
| 2012 | — | $-3579.00 | — | — | — |
| 2013 | — | $-1.38M | — | — | — |
| 2014 | $0.00 | $-2.77M | — | — | — |
| 2015 | $200000.00 | $-2.85M | 100.00% | -1,323.00% | -1,426.00% |
| 2016 | $0.00 | $-2.13M | — | — | — |
| 2017 | $0.00 | $-1.81M | — | — | — |
| 2018 | $0.00 | $-2.13M | — | — | — |
| 2019 | $0.00 | $-2.39M | — | — | — |
| 2020 | $0.00 | $-3.26M | — | — | — |
| 2021 | $0.00 | $-6.73M | — | — | — |
| 2022 | $0.00 | $-6.31M | — | — | — |
| 2023 | $0.00 | $-5.09M | — | — | — |
| 2024 | $0.00 | $-3.59M | — | — | — |
| 2025 | $0.00 | $-6.01M | — | — | — |